People with phenylketonuria cannot break down a substance in food called phenylalanine. Following a phenylketonuria diet is the main treatment for preventing serious symptoms. People with ...

Diseases or injuries can result in dramatic changes in metabolite blood levels. For example, increased blood levels of the amino acid phenylalanine are characteristic of the genetic disorder ...

PTC Therapeutics receives Health Canada nod for Sephience to treat children and adults living with phenylketonuria: Toronto Friday, December 12, 2025, 18:00 Hrs [IST] PTC Therapeu ...

PTC Therapeutics Canada ULC announced that Health Canada has approved Sephience™ (sepiapterin) for the treatment of children and adults living with phenylketonuria (PKU). The approval includes broad ...

What Is Sephience, and Why Does It Matter? Sephience (sepiapterin) is a new oral medication approved by the FDA to treat a rare inherited condition known as phenylketonuria (PKU) in adults and ...

Phenylketonuria is an inherited disease characterized by progressive mental retardation and seizures because the individual is deficient in the protein PAH. Most of the genetic mutations that cause ...

WARREN, N.J., June 23, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Sephience™ (sepiapterin) was granted marketing authorization by the European Commission for the ...

"Phenylketonuria Market Insight, Epidemiology and Market Forecast report" DelveInsight’s comprehensive Phenylketonuria Market Insight, Epidemiology and Market Forecast - 2034 report provides crucial ...

PTC Therapeutics Inc. will be launching its oral phenylketonuria therapy, Sephience (sepiapterin) in both the U.S. and Europe this summer, following the U.S. FDA approval just ahead of its July 29 ...

This page lists all known medications that could potentially lead to 'Phenylketonuria' as a side effect. It's important to note that mild side effects are quite common with medications. The medication ...